2023
Unlocking the Proteome - The NULISA™ Platform
Entrant Company
Halteres Associates
Category
Video - Medical
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
BRC Imagination Arts
Category
Experiential & Immersive - Experiential & Immersive / Other___
Country / Region
United States
Entrant Company
CHINA CICC WEALTH MANAGEMENT SECURITIES COMPANY LIMITED
Category
Publication - Publication / Other___
Country / Region
China
Entrant Company
National Hockey League
Category
Video - Branding
Country / Region
United States
Entrant Company
PACO Collective
Category
Advertising - Magazine Ad (Single)
Country / Region
United States